Sampre Nutritions Ltd (530617)
📢 Recent Corporate Announcements
Sampre Nutritions has received in-principle approval from BSE Limited for issuing 17,70,710 equity shares (face value ₹5 each) to promoters on a preferential basis. The allotment is priced at not less than ₹42 per share, converting existing promoter unsecured loans into equity. At ₹42 per share, this translates to a debt-to-equity conversion of at least ₹7.44 crore, representing ~24% of the company's current market cap of ₹31 crore.
- BSE in-principle approval letter dated 28 August 2026 received for preferential issue.
- Issuance and allotment of 17,70,710 equity shares (face value ₹5 each) to promoter/promoter group.
- Minimum issue price fixed at ₹42 per share against conversion of promoter unsecured loans.
- Total minimum loan conversion size stands at ~₹7.44 crore against total debt of ₹18 crore.
Sampre Nutritions has scheduled its 35th Annual General Meeting (AGM) for September 4, 2026, to be held via video conferencing. The company has dispatched the Annual Report for FY 2025-26, which includes a corrigendum to rectify typographical errors regarding the appointment of the Scrutinizer. This follows a financial turnaround in FY26, where the company reported a net profit of ₹3.08 cr compared to a loss of ₹7.67 cr in FY25. Investors should note the low promoter holding of 14.04% and the high geographic concentration of operations in Telangana.
- 35th Annual General Meeting scheduled for September 4, 2026, at 11:00 A.M.
- FY26 annual revenue reached ₹43.35 cr, a 72% increase over FY25 revenue of ₹25.12 cr
- Company turned profitable in FY26 with a net profit of ₹3.08 cr vs a loss of ₹7.67 cr in FY25
- Promoter holding remains low at 14.04% as of June 2026
- Market capitalization stands at ₹34 cr with a TTM P/E of 9.6
Sampre Nutritions has scheduled its 35th Annual General Meeting (AGM) for September 4, 2026, at 11:00 AM via video conferencing. The company issued a corrigendum to correct typographical errors in the original notice specifically regarding the date of appointment of the scrutinizer and the publication of results. These corrections are administrative and do not affect the substance of the resolutions or the financial data in the Annual Report. The company currently operates with a small market cap of Rs 34 Cr and reported TTM revenue of Rs 47 Cr.
- 35th Annual General Meeting scheduled for September 4, 2026
- Meeting to be held at 11:00 A.M. (IST) via Video Conferencing
- Corrigendum issued to fix typographical errors regarding the scrutinizer's appointment date
- Company reported TTM revenue of Rs 47 Cr against a market cap of Rs 34 Cr
Sampre Nutritions has released its Annual Report for FY 2025-26 and scheduled its 35th Annual General Meeting (AGM) for September 4, 2026. The company reported a significant financial turnaround in FY26, with revenue growing 72.5% to ₹43.35 Cr from ₹25.12 Cr in FY25. Net profit turned positive at ₹3.08 Cr compared to a loss of ₹7.67 Cr in the previous year. The AGM will be conducted via video conferencing to discuss these results and future operations.
- 35th Annual General Meeting scheduled for September 4, 2026, at 11:00 A.M. IST
- FY26 Revenue grew to ₹43.35 Cr, a 72.5% increase over the previous year's ₹25.12 Cr
- Net profit for FY26 reached ₹3.08 Cr, recovering from a net loss of ₹7.67 Cr in FY25
- Promoter holding remains low at 14.04% as of June 2026
- Company operates two manufacturing units located in Medchal, Telangana
Sampre Nutritions has convened its 35th Annual General Meeting (AGM) for September 4, 2026. The key agenda item is a special resolution to increase the annual remuneration of Whole-Time Director Vishal Ratan Gurbani from ₹18 lakh to ₹60 lakh, effective April 1, 2026. This proposed ₹60 lakh salary represents approximately 19.5% of the company's FY26 net profit of ₹3.08 crore. The board justifies the hike citing his expanded roles in business development and technical oversight.
- 35th AGM scheduled for September 4, 2026, via video conferencing
- Proposed 233% increase in remuneration for Whole-Time Director Vishal Ratan Gurbani
- New proposed annual salary of ₹60,00,000, up from the current ₹18,00,000
- The incremental cost of ₹42 lakh per annum represents roughly 13.6% of FY26 net profit
- Cut-off date for e-voting and participation is set for August 28, 2026
Sampre Nutritions reported a 36.6% YoY increase in standalone revenue to ₹14.85 Cr for Q1 FY27, though net profit remained stagnant at ₹0.70 Cr. The company's operating expenses rose sharply, with employee benefit expenses increasing from ₹3.17 Cr to ₹5.10 Cr YoY. A significant proposal was made to increase the remuneration of Whole-Time Director Vishal Ratan Gurbani from ₹18 Lakhs to ₹60 Lakhs per annum, effective April 2026. This proposed salary represents approximately 15% of the company's TTM Net Profit of ₹4 Cr, which may draw investor scrutiny at the upcoming AGM.
- Standalone revenue from operations increased to ₹14.85 Cr in Q1 FY27 from ₹10.87 Cr in Q1 FY26.
- Net profit for the quarter remained flat at ₹0.70 Cr compared to ₹0.71 Cr in the same period last year.
- Proposed a 233% increase in remuneration for WTD Vishal Ratan Gurbani to ₹60,00,000 per annum.
- Employee benefit expenses surged by 61% YoY to ₹5.10 Cr during the quarter.
- Total expenses for the quarter rose to ₹14.12 Cr from ₹10.18 Cr in the previous year's corresponding quarter.
Sampre Nutritions has scheduled a board meeting on August 5, 2026, to approve Q1 FY27 results and finalize the 35th AGM notice. A key agenda item is the proposal to increase the remuneration of Whole-Time Director Vishal Gurbani from ₹18 lakhs to ₹60 lakhs per annum, effective retroactively from April 1, 2026. This 233% hike is significant for a company with a ₹50 crore market cap, representing approximately 15% of its TTM PAT of ₹4 crore. Investors should also note the low promoter holding of 14.04% and the sharp 68.7% decline in stock price over the last three months.
- Board meeting scheduled for August 5, 2026, to approve Q1 FY27 financial results.
- Proposed 233% increase in annual remuneration for Whole-Time Director Vishal Gurbani.
- Remuneration to rise from ₹18,00,000 to ₹60,00,000 per annum effective April 1, 2026.
- Proposed annual salary of ₹60 lakhs represents ~15% of the TTM PAT of ₹4 crore.
- Promoter holding remains low at 14.04% as of June 2026.
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Capacity Expansion
Current manufacturing facilities are located at Unit-1 (Plot No. 133, I.E, Medchal, Telangana) and Unit-2 (Plot No. 127, 128, Royes Building, I.E. Medchal, Telangana). Specific capacity figures in MT or units and planned expansion timelines are not disclosed in available documents.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Geographic Concentration Risk
The company's primary manufacturing operations are concentrated in Medchal, Telangana, which may expose the business to regional regulatory or infrastructure risks.
